Editor of Patient Care Online.
Study: 72% of Asymptomatic UTI Patients Receive Unnecessary Antibiotics
Researchers recommend expanding antimicrobial stewardship efforts to better track and reduce unnecessary antibiotic use.
Investigational Keto Diet Pill Shows Promise in Phase 1 Trial: Daily Dose
Your daily dose of the clinical news you may have missed.
Universal ED Syphilis Screening Outperforms Targeted Approaches, Study Shows
CROI 2025: Researchers reported that a universal syphilis screening program identified more cases than programs targeting specific patient populations.
AGA: AI-Assisted Colonoscopy Increases Adenoma Detection, But Long-Term Benefits Unclear
New AGA guidelines conclude that it is not clear whether computer-aided detection systems for colonoscopy should be recommended for routine widespread use.
Dupilumab Found Beneficial in COPD with Type 2 Inflammation: Daily Dose
Improved HPV Vaccination Coverage May Help Prevent Noncervical Cancers in People with HIV
CROI 2025: Increased HPV vaccine coverage could reduce HIV cases by thousands, according to a new study.
US Adult Vaccination Snapshots: Current Coverage, Trends, and Concerns
Get the latest immunization updates, data on racial disparities, and practical guidance for clinical practice, here.
Roflumilast Cream Shows Strong Tolerability in Patients with AD Failing Other Topicals: Daily Dose
Managing Atopic Dermatitis in Special Populations: Expert Insights for Primary Care
In an interview at AAD 2025, Katrina Abuabara, MD, stressed the importance of collaboration between primary care physicians and dermatologists.
Topical Steroid Withdrawal: Study Identifies Mitochondrial Dysfunction as a Potential Target for Treatment
NIH researchers also proposed new diagnostic criteria that include a combination of major and minor symptoms, offering improved sensitivity for identifying TSW cases.
FDA Greenlights First Rivaroxaban Generics (2.5 mg): Daily Dose
Early Responsive Parenting Intervention Shows Modest, Short-Term Impact on Childhood Obesity
New data shows that early-life responsive parenting can lower childhood BMI, but effects diminished by age 9, highlighting the need for ongoing obesity prevention efforts.
Emergence of Trichophyton Indotineae: A Call for Culture-Driven Antifungal Therapy
Elizabeth Swanson, MD, shares how the rise of T.indotineae, a terbinafine-resistant fungal species, has shifted her treatment approach.
Epinephrine Nasal Spray Shows Rapid Symptom Relief in Children: Daily Dose
Rethinking Shingles in Children: Expert Insights for Primary Care
Shingles is increasingly being observed in healthy, immunocompetent children. Elizabeth Swanson, MD, discusses how to recognize and respond.
Measles Resurgence and Vaccine Efficacy: A Conversation with Elizabeth Swanson, MD
Dr Swanson discusses the resurgence of measles and emphasizes the safety and efficacy of the measles vaccine.
Bionic Pancreas for Type 1 Diabetes Found Feasible to Implement in Primary Care
The iLet bionic pancreas system conferred an average glucose of less than 183 mg/dL in 97% of adults with T1D in a small study.
Dupilumab Cuts Food Allergy IgE Levels in Small Study: Daily Dose
Hand, Foot, and Mouth Disease Update: A Conversation with Elizabeth Swanson, MD
Elizabeth Swanson, MD, discusses the changing face of HFMD, focusing on the increasingly prevalent coxsackievirus A6 strain and its unique characteristics
JiaDe Yu, MD: When to Refer Pediatric Patients with Suspected Contact Dermatitis
In an interview at AAD 2025, Dr Yu emphasized the importance of managing contact dermatitis early and effectively to prevent long-term complications.
Dermatology Therapeutics: Updates for Primary Care from AAD 2025
Research included new findings on topical and systemic treatments for atopic dermatitis, psoriasis, alopecia areata, and other chronic skin disorders.
FDA Approves Neffy 1 mg Epinephrine Nasal Spray: Daily Dose
Study: COVID-19 Pandemic Disruptions in Cancer Screening Show Uneven Recovery in 2023
Cervical cancer screening rates remained below prepandemic levels, while rates for breast and colorectal cancers rebounded from pandemic declines.
Women as Young as Age 30 May Experience Perimenopause Symptoms: Daily Dose
Contact Dermatitis: Expert Insights on First-Line and Emerging Therapies
JiaDe 'Jeff' Yu, MD, discusses first-line therapies, emerging biologics, and the potential of molecular biomarkers for improved diagnosis.
Advances in Dermatology Therapeutics: Key Insights from AAD 2025
Highlights include new data on roflumilast cream 0.15%, an investigational anti-OX40 ligand monoclonal antibody, and more.
JiaDe Yu, MD: Key Signs of Allergic Contact Dermatitis in Children
AAD 2025. JiaDe Yu, MD, discusses key clinical signs of pediatric ACD, when to consider patch testing, and how identifying contact allergens can improve patient care.
Elizabeth Swanson, MD: When HSV Causes Big Dermatologic Problems
Elizabeth Swanson, MD, breaks down the role of the Herpes Simplex Virus in 3 special circumstances, part of her AAD 2025 presentation, "Big Rashes In Little Patients."
Recognizing Allergic Contact Dermatitis in Children: Expert Pearls at AAD 2025
JiaDe Yu, MD, shares key takeaways from his presentation on pediatric allergic contact dermatitis.
The Complexities of Treating Rosacea, with Benjamin Ungar, MD
Benjamin Ungar, MD, explains the phenotypic and molecular manifestations of Rosacea, and the work still needed to develop targeted treatments.
